Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.37 |
| ▸ | ESR1 | P03372 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.31 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL685573 | 0.88 | — | — | |
| SCHEMBL16109561 | 0.88 | ALDH1A1 (0.50) | ALDH1A1RIPK1MAPK1 | |
| SCHEMBL10192039 | 0.87 | ALDH1A1 (0.39) | ALDH1A1NR1H2 | |
| SCHEMBL16309032 | 0.82 | ALDH1A1 (0.46) | ALDH1A1RIPK1MAPK1 | |
| SCHEMBL16309031 | 0.82 | ALDH1A1 (0.46) | ALDH1A1RIPK1MAPK1 | |
| SCHEMBL20362799 | 0.81 | CNR2 (0.32) | ALDH1A1NR1H2 | |
| SCHEMBL24775454 | 0.79 | ALDH1A1 (0.43) | ALDH1A1RIPK1 | |
| SCHEMBL16850410 | 0.79 | ALDH1A1 (0.43) | ALDH1A1RIPK1 | |
| SCHEMBL16133774 | 0.79 | ALDH1A1 (0.43) | ALDH1A1RIPK1 | |
| SCHEMBL11930043 | 0.79 | ALDH1A1 (0.43) | ALDH1A1RIPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10020512-B2 | Polymer for use as protective layers and other components in electrochemical cells | SION POWER CORPORATION (US) | 2018-07-10 | — | — | US | disclosed |
| US-20170001990-A1 | PIPERIDINE-DIONE DERIVATIVES | GENENTECH, INC. (US) | 2017-01-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170001990-A1 | PIPERIDINE-DIONE DERIVATIVES | DRD4, ADORA1, ADORA3 | ALDH1A1 132/4885NR1H2 2494/4885ESR1 512/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.